neuroprotective protein therapy (Apollo Life Sciences)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameneuroprotective protein therapy (Apollo Life Sciences)
Drug Alias Namestroke-associated apoptosis inhibitor (Apollo Life Sciences)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApoptosis inhibitorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Life Sciences
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A